share_log
Breakings ·  Dec 21, 2024 05:30
Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (Sotagliflozin)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment